Organ devices will have higher clinical trial requirements, and the research and development cycle will be longer than that of in vitro reagents or devices). From the perspective of R&D risk and unprofitable profit balance, we can focus on three types of medical device R&D and manufacturing enterprises with core technologies and leading advantages.
2. At present, the development of the industry is relatively backward, which leads to more room for growth.
3. There are many medical device enterprises with small scale and fierce competition in low-end products.
4. Consumables in medical devices have the concept of consumer goods, and their future growth is widely optimistic. price
There is a strong transfer ability in the world, which can resolve the risk of rising raw material prices.
During the Twelfth Five-Year Plan period, we will vigorously support the development of domestic medical devices. When implementing centralized bidding and purchasing,
Give priority to purchasing domestic medical devices.
6. The import substitution trend of high-end equipment and large medical equipment is obvious, but the sales are particularly complicated.
7. For medical diagnostic equipment enterprises, focus on product technical sustainability, cost performance and marketing ability;
Competition is still management and marketing.